The consistent presence of PIK3CA mutations across all groups reinforces its role as a foundational driver of CRC biology, while the variable involvement of ancillary regulators such as INPP4B, TSC1, and RICTOR underscores the complexity of PI3K pathway disruption. This evidence concerns the gene INPP4B and colorectal carcinoma.